These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23861493)

  • 61. Protein-engineered hydrogels enhance the survival of induced pluripotent stem cell-derived endothelial cells for treatment of peripheral arterial disease.
    Foster AA; Dewi RE; Cai L; Hou L; Strassberg Z; Alcazar CA; Heilshorn SC; Huang NF
    Biomater Sci; 2018 Feb; 6(3):614-622. PubMed ID: 29406542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High-throughput identification of small molecules that affect human embryonic vascular development.
    Vazão H; Rosa S; Barata T; Costa R; Pitrez PR; Honório I; de Vries MR; Papatsenko D; Benedito R; Saris D; Khademhosseini A; Quax PH; Pereira CF; Mercader N; Fernandes H; Ferreira L
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3022-E3031. PubMed ID: 28348206
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells.
    Melero-Martin JM; De Obaldia ME; Kang SY; Khan ZA; Yuan L; Oettgen P; Bischoff J
    Circ Res; 2008 Jul; 103(2):194-202. PubMed ID: 18556575
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Co-Seeding Human Endothelial Cells with Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on Calcium Phosphate Scaffold Enhances Osteogenesis and Vascularization in Rats.
    Liu X; Chen W; Zhang C; Thein-Han W; Hu K; Reynolds MA; Bao C; Wang P; Zhao L; Xu HHK
    Tissue Eng Part A; 2017 Jun; 23(11-12):546-555. PubMed ID: 28287922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.
    Kawamura M; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura T; Kuratani T; Daimon T; Shimizu T; Okano T; Sawa Y
    Circulation; 2012 Sep; 126(11 Suppl 1):S29-37. PubMed ID: 22965990
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The generation of hybrid electrospun nanofiber layer with extracellular matrix derived from human pluripotent stem cells, for regenerative medicine applications.
    Shtrichman R; Zeevi-Levin N; Zaid R; Barak E; Fishman B; Ziskind A; Shulman R; Novak A; Avrahami R; Livne E; Lowenstein L; Zussman E; Itskovitz-Eldor J
    Tissue Eng Part A; 2014 Oct; 20(19-20):2756-67. PubMed ID: 25185111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Follistatin-Like 3 Enhances the Function of Endothelial Cells Derived from Pluripotent Stem Cells by Facilitating β-Catenin Nuclear Translocation Through Inhibition of Glycogen Synthase Kinase-3β Activity.
    Kelaini S; Vilà-González M; Caines R; Campbell D; Eleftheriadou M; Tsifaki M; Magee C; Cochrane A; O'neill K; Yang C; Stitt AW; Zeng L; Grieve DJ; Margariti A
    Stem Cells; 2018 Jul; 36(7):1033-1044. PubMed ID: 29569797
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fibroblast growth factor-2 facilitates rapid anastomosis formation between bioengineered human vascular networks and living vasculature.
    Lin RZ; Melero-Martin JM
    Methods; 2012 Mar; 56(3):440-51. PubMed ID: 22326880
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion.
    Janic B; Guo AM; Iskander AS; Varma NR; Scicli AG; Arbab AS
    PLoS One; 2010 Feb; 5(2):e9173. PubMed ID: 20161785
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells.
    Patsch C; Challet-Meylan L; Thoma EC; Urich E; Heckel T; O'Sullivan JF; Grainger SJ; Kapp FG; Sun L; Christensen K; Xia Y; Florido MH; He W; Pan W; Prummer M; Warren CR; Jakob-Roetne R; Certa U; Jagasia R; Freskgård PO; Adatto I; Kling D; Huang P; Zon LI; Chaikof EL; Gerszten RE; Graf M; Iacone R; Cowan CA
    Nat Cell Biol; 2015 Aug; 17(8):994-1003. PubMed ID: 26214132
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of tissue engineered constructs in vivo.
    Herrmann M; Binder A; Menzel U; Zeiter S; Alini M; Verrier S
    Stem Cell Res; 2014 Nov; 13(3 Pt A):465-77. PubMed ID: 25460607
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuropilin-1 Mediated Arterial Differentiation of Murine Pluripotent Stem Cells.
    Kim D; Lee V; Dorsey TB; Niklason LE; Gui L; Dai G
    Stem Cells Dev; 2018 Apr; 27(7):441-455. PubMed ID: 29415620
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differentiation, Evaluation, and Application of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.
    Lin Y; Gil CH; Yoder MC
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2014-2025. PubMed ID: 29025705
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endothelial Progenitor Cells for the Vascularization of Engineered Tissues.
    Peters EB
    Tissue Eng Part B Rev; 2018 Feb; 24(1):1-24. PubMed ID: 28548628
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficient generation of endothelial cells from induced pluripotent stem cells derived from a patient with peripheral arterial disease.
    Boonkaew B; Suwanpitak S; Pattanapanyasat K; Sermsathanasawadi N; Wattanapanitch M
    Cell Tissue Res; 2022 Apr; 388(1):89-104. PubMed ID: 35072793
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Engineering vascularized flaps using adipose-derived microvascular endothelial cells and mesenchymal stem cells.
    Freiman A; Shandalov Y; Rosenfeld D; Shor E; Ben-David D; Meretzki S; Levenberg S; Egozi D
    J Tissue Eng Regen Med; 2018 Jan; 12(1):e130-e141. PubMed ID: 28382732
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional characterization of human pluripotent stem cell-derived arterial endothelial cells.
    Zhang J; Chu LF; Hou Z; Schwartz MP; Hacker T; Vickerman V; Swanson S; Leng N; Nguyen BK; Elwell A; Bolin J; Brown ME; Stewart R; Burlingham WJ; Murphy WL; Thomson JA
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6072-E6078. PubMed ID: 28696312
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases.
    Yoo CH; Na HJ; Lee DS; Heo SC; An Y; Cha J; Choi C; Kim JH; Park JC; Cho YS
    Biomaterials; 2013 Nov; 34(33):8149-60. PubMed ID: 23896001
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A High-Efficiency Method for the Production of Endothelial Cells from Human Induced Pluripotent Stem Cells.
    Pavlova M; McGarvey SS; Bilousova G; Kogut I
    Methods Mol Biol; 2022; 2549():169-186. PubMed ID: 33755906
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inverse and reciprocal regulation of p53/p21 and Bmi-1 modulates vasculogenic differentiation of dental pulp stem cells.
    Zhang Z; Oh M; Sasaki JI; Nör JE
    Cell Death Dis; 2021 Jun; 12(7):644. PubMed ID: 34168122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.